Background
Methods
Study design and setting
Source study characteristics
Source study quality assessment
Development of individual patient database
Patient population
Lung ultrasound
Statistical analysis
Results
Source study with quality assessment, and patient characteristics
All patients (n = 872) | PE positive (n = 279) | PE negative (n = 593) | P value | |
---|---|---|---|---|
Mean age ± SD | 69.6 ± 16 | 69.2 ± 16 | 69.8 ± 15.8 | 0.549 |
Women | 452 (51.8%) | 151 (54.1%) | 301 (50.8%) | 0.354 |
Shock/hypotension | 89 (10.2%) | 23 (8.2%) | 66 (11.1%) | 0.189 |
Palpitations | 85 (9.7%) | 31 (11.1%) | 54 (9.1%) | 0.352 |
Dyspnea | 561 (64.3%) | 206 (73.8%) | 355 (59.9%) | < 0.001 |
Chest pain in general | 310 (35.6%) | 92 (33%) | 218 (36.8%) | 0.276 |
Pleuritic chest pain | 217 (24.9%) | 65 (23.3%) | 152 (25.6%) | 0.457 |
Signs and symptoms of DVT | 205 (23.5%) | 118 (42.3%) | 87 (14.7%) | < 0.001 |
Alternative diagnosis less likely than PE | 427 (48.7%) | 183 (65.6%) | 244 (41.1%) | < 0.001 |
HR > 100 bpm | 302 (34.6%) | 93 (33.3%) | 209 (35.2%) | 0.580 |
Immobilization or surgery | 193 (22.1%) | 59 (21.1%) | 134 (22.6%) | 0.630 |
Previous DVT or PE | 122 (14%) | 54 (19.4%) | 68 (11.5%) | 0.002 |
Hemoptysis | 35 (4%) | 11 (3.9%) | 24 (4%) | 0.942 |
Malignancy | 169 (19.4%) | 69 (24.7%) | 100 (16.9%) | 0.006 |
Wells score | 3.5 ± 2.5 | 4.6 ± 2.6 | 2.9 ± 2.3 | < 0.001 |
All patients n = 872 | No pleuritic cp n = 655 | Pleuritic cp n = 217 | |
---|---|---|---|
Pulmonary embolism | 279 (32%) | 214 (32.7%) | 65 (30%) |
Pneumonia | 169 (19.4%) | 121 (18.5%) | 48 (22.1%) |
Heart failure | 80 (9.2%) | 72 (11%) | 8 (3.7%) |
Musculo-skeletal chest pain | 53 (6.1%) | 11 (1.7%) | 42 (19.4%) |
COPD/pulmonary fibrosis | 60 (6.9%) | 55 (8.4%) | 5 (2.3%) |
Pleural effusion | 38 (4.4%) | 21 (3.2%) | 17 (7.8%) |
Syncope | 37 (4.2%) | 35 (5.3%) | 2 (0.9%) |
Tachyarrhythmia | 32 (3.7%) | 27 (4.1%) | 5 (2.3%) |
Acute coronary syndrome | 19 (2.2%) | 17 (2.6%) | 2 (0.9%) |
Lung cancer | 20 (2.3%) | 13 (2%) | 7 (3.2%) |
Psychogenic dyspnea | 19 (2.2%) | 16 (2.4%) | 3 (1.4%) |
Aortic dissection | 6 (0.7%) | 6 (0.9%) | 0 |
Pericardial effusion | 5 (0.6%) | 3 (0.5%) | 2 (0.9%) |
Miscellaneous | 55 (6.3%) | 44 (6.7%) | 11 (5.1%) |
Lung ultrasound examination
Population, n | True pos | False pos | True neg | False neg |
---|---|---|---|---|
All patients, 872 | 159 | 30 | 563 | 120 |
No pleuritic chest pain, 655 | 106 | 23 | 418 | 108 |
Pleuritic chest pain, 217 | 53 | 7 | 145 | 12 |
Scan in the most painful area, 156* | 37 | 5 | 104 | 10 |
Population n | AUC | Sens | Spec | PPV | NPV | LR + | LR- |
---|---|---|---|---|---|---|---|
All patients 872 | 76 (72.1–79.8) | 57% (51–62.9) | 94.9% (92.9–96.6) | 84.1% (78.1–89) | 82.4% (79.4–85.2) | 11.3 (7.83–16.20) | 0.45 (0.40–0.52) |
No pleuritic cp 655 | 72.2 (67.6–76.7) | 49.5% (42.7–56.4) | 94.8% (92.3–97.7) | 82.2% (74.5–88.4) | 79.5% (75.8–82.8) | 9.50 (6.24–14.46) | 0.53 (0.47–0.61) |
Pleuritic cp 217 | 88.5 (82.6–94.4) | 81.5% (70–90.1) | 95.4% (90.7–98.1) | 88.3% (77.4–95.2) | 92.4% (87–96) | 17.71 (8.51–36.84) | 0.19 (0.11–0.31) |
Scan in the painful area 156* | 87.1 (79.7–94.4) | 78.7% (64.3–89.3) | 95.4% (89.6–98.5) | 88.1% (75.6–99.6) | 91.2% (85.7–94.7) | 17.16 (7.2–40.92) | 0.22 (0.13–0.39) |
Strategies to rule-out PE: wells score + d-dimer vs wells score + LUS
-Wells score ≤ 4 -Negative d-dimer | -Wells score ≤ 4 -Negative LUS | -Wells score ≤ 4 -Negative d-dimer -Negative LUS | |
---|---|---|---|
Failure rate* | 4.1% (1.4–9.4) | 12.4% (8.5–17.4) | 0.9% (0.02–4.9) |
Efficiency** | 26.8% (22.8–31) | 51.7% (46.9–56.4) | 24.8% (20.9–29.1) |
Sensitivity | 96.6% (92.3–98.9) | 80.5% (73.3–86.6) | 99.3% (96.3–100) |
Specificity | 38.4% (32.9–44.1) | 67.5% (61.9–72.8) | 36.8% (31.3–42.5) |
PPV | 43.5% (41.2–45.8) | 55% (50.6–59.5) | 43.7% (41.5–45.8) |
NPV | 95.9% (90.6–98.2) | 87.6% (83.9–91.2) | 99.1% (94–99.9) |
LR + | 1.57 (1.43–1.72) | 2.48 (20.07–2.97) | 1.57 (1.44–1.71) |
LR- | 0.09 (0.04–0.21) | 0.29 (0.21–0.41) | 0.02 (0–0.13) |
- Wells score ≤ 4 - Negative d-dimer | - Wells score ≤ 4 - Negative LUS | - Wells score ≤ 4 - Negative d-dimer - Negative LUS | - Wells score ≤ 4 - Negative LUS (painful area) | |
---|---|---|---|---|
Failure rate* | 6.7% (1.9–16.2) | 3.7% (0.8–10.6) | 0% (0–6.5) | 4.9% (1.36–12.2) |
Efficiency** | 42.5% (34.3–51.2) | 56.7% (48.1 -65) | 39% (30.9–47.6) | 57.4% (48.8–65.7) |
Sensitivity | 90.7% (77.9–97.4) | 93% (80.9–98.5) | 100% (91.8–100) | 90.7% (77.9–97.4) |
Specificity | 57.1% (46.7–67.1) | 78.6% (69.1–86.2) | 56.1% (45.7–66-1) | 78.6% (69.1–86.2) |
PPV | 48.1% (42–54.3) | 65.6% (55.4–73.7) | 50% (44.4–55.6) | 65% (55.7–73.3) |
NPV | 93.3% (84.4–97.3) | 96.2% (89.6–98.7) | 100% | 95.1% (88.3–98) |
LR + | 2.12 (1.65–2.71) | 4.34 (2.95–6.4) | 2.28 (1.82–2.85) | 4.23 (2.86–6.26) |
LR- | 0.16 (0.06–0.42) | 0.09 (0.03–0.27) | 0 | 0.12 (0.05–0.3) |